Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04372927
Title ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington

lung non-small cell carcinoma


Cisplatin + Durvalumab + Pemetrexed Disodium

Cisplatin + Durvalumab + Etoposide

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.